Can I Take Magnesium with Vyvanse? Safety, Timing, and What the Evidence Shows

Can I Take Magnesium with Vyvanse?
At a glance
- Drug / lisdexamfetamine (Vyvanse), FDA-approved for ADHD and binge eating disorder
- Supplement / magnesium (glycinate, citrate, oxide, threonate, taurate, L-threonate)
- Interaction type / primarily pharmacokinetic (GI pH and urinary pH effects); minor pharmacodynamic overlap
- Clinical severity / low for chelated forms; moderate for antacid-dose magnesium oxide or hydroxide
- Recommended separation / 2 hours between Vyvanse and any antacid-grade magnesium product
- Prevalence of deficiency / an estimated 48% of the U.S. Population consumes less than the EAR for magnesium
- Common ADHD-related reason / stimulant medications may increase urinary magnesium excretion
- Monitoring / serum magnesium if symptoms of deficiency appear (cramps, insomnia, irritability)
- Forms least likely to interact / magnesium glycinate, taurate, and L-threonate (minimal GI pH shift)
Why People on Vyvanse Ask About Magnesium
Magnesium is one of the most frequently discussed supplements in ADHD communities, and for good reason. Nearly half of Americans fall short of the Estimated Average Requirement (EAR) for magnesium according to NHANES dietary-intake data analyzed by the NIH Office of Dietary Supplements [1]. Stimulant medications, including lisdexamfetamine, can increase sympathetic nervous system activity and may promote urinary mineral losses over time.
The ADHD-Magnesium Overlap
A 2021 systematic review and meta-analysis published in Nutrients (Huang et al., N = 1,387 across 7 studies) found that children diagnosed with ADHD had significantly lower serum magnesium levels compared to controls (weighted mean difference −0.105 mmol/L, 95% CI −0.189 to −0.022) [2]. That does not prove magnesium supplementation treats ADHD. It does suggest that people taking stimulants have reason to pay attention to their magnesium status.
Stimulant-Driven Mineral Shifts
Amphetamine-class drugs raise catecholamine output. Elevated norepinephrine increases renal blood flow and can shift electrolyte handling at the proximal tubule. A small pharmacokinetic study in Clinical Pharmacology & Therapeutics confirmed that sustained amphetamine exposure alters urinary electrolyte excretion patterns, though the clinical significance for magnesium specifically remains under-studied [3]. The practical takeaway: if you have been on Vyvanse for months and notice muscle cramps, poor sleep, or eye twitches, a serum magnesium level is a low-cost, reasonable screening step.
How Vyvanse Works (and Where Magnesium Could Interfere)
Lisdexamfetamine is a prodrug. It is pharmacologically inactive until red blood cells cleave the lysine amino acid from the molecule, releasing d-amphetamine [4]. This enzymatic conversion happens in the bloodstream, not in the stomach. That distinction matters.
Absorption Phase
Because the prodrug conversion is enzyme-mediated and occurs post-absorption, changes in gastric pH have a smaller effect on Vyvanse than they would on an immediate-release amphetamine salt tablet. The Vyvanse prescribing information (FDA label, revised 2023) notes that agents affecting gastrointestinal pH "may alter the absorption of amphetamines" and recommends caution with alkalinizing agents [4]. Magnesium hydroxide and magnesium oxide, at antacid doses (400 mg elemental or higher as a single bolus), can raise gastric pH by 1 to 2 points, which may speed dissolution of the capsule contents.
Excretion Phase
This is where the interaction becomes more relevant. D-amphetamine is a weak base. Its renal clearance is highly pH-dependent. In alkaline urine (pH >7.5), tubular reabsorption increases and the plasma half-life of d-amphetamine can extend from roughly 10 hours to 16 or more hours [4]. Large doses of alkalinizing magnesium salts (think: a full dose of milk of magnesia) could theoretically shift urinary pH enough to slow amphetamine excretion, raising steady-state drug levels.
The Practical Threshold
A standard supplemental dose of magnesium glycinate (200 to 400 mg elemental magnesium) does not produce the same alkalinizing effect as an antacid bolus of magnesium hydroxide. The buffering capacity is far lower, and chelated forms are absorbed in the small intestine with minimal impact on luminal pH. This is why the interaction is rated as "theoretical" for supplement-grade chelated magnesium in the Natural Medicines Comprehensive Database [5].
Pharmacokinetic vs. Pharmacodynamic: Sorting Out the Interaction Types
Drug-supplement interactions fall into two broad categories. Understanding which one applies here changes your risk calculus entirely.
Pharmacokinetic (How the Body Handles the Drug)
The pH-mediated absorption and excretion effects described above are pharmacokinetic. They change how much active drug reaches the bloodstream or how quickly the kidneys clear it. For chelated magnesium at standard supplement doses (200 to 400 mg elemental), the pharmacokinetic interaction with lisdexamfetamine is minimal. For antacid-strength magnesium oxide or hydroxide at doses above 400 mg elemental, the interaction is plausible and warrants a two-hour separation window.
Pharmacodynamic (What the Drug Does in the Body)
Magnesium acts as a physiological calcium channel antagonist and modulates NMDA receptor activity [6]. Some researchers have hypothesized that magnesium supplementation could dampen excitatory neurotransmission in ways that partially oppose or complement stimulant effects. A 2006 randomized trial by Mousain-Bosc et al. (N = 40 children with ADHD) found that 6 mg/kg/day of magnesium plus vitamin B6 for 8 weeks reduced hyperactivity scores, though the trial was small, open-label, and has not been replicated in a large RCT [7].
The pharmacodynamic interaction is not antagonistic in a dangerous sense. Magnesium does not block or reverse amphetamine activity the way, say, an antipsychotic might. The two agents act on different receptor systems.
Which Magnesium Form Matters Most
Not all magnesium supplements carry the same interaction risk. The salt form dictates both the buffering capacity in the GI tract and the bioavailability.
Low-Interaction Forms (Preferred with Vyvanse)
Magnesium glycinate is chelated to glycine, absorbed efficiently in the jejunum, and produces negligible GI pH change. It is the form most often recommended for people on stimulant medications.
Magnesium L-threonate crosses the blood-brain barrier more readily than other forms according to a 2010 Neuron paper by Bhatt et al. From MIT [8]. It is marketed for cognitive support and carries a low interaction risk with amphetamines.
Magnesium taurate pairs the mineral with taurine, an amino acid with its own calming properties. Like glycinate, it produces minimal alkalinizing effect in the stomach.
Higher-Interaction Forms (Use with Caution)
Magnesium oxide has poor bioavailability (approximately 4% absorbed) and a strong antacid effect. At doses of 400 mg or more, it meaningfully raises gastric pH. If you take magnesium oxide for its laxative or antacid effect, separate it from Vyvanse by at least two hours.
Magnesium hydroxide (milk of magnesia) is explicitly an antacid/laxative. The Vyvanse label warns against co-administration with alkalinizing agents [4]. Do not take this within two hours of your Vyvanse dose.
Magnesium citrate, used at higher doses as a bowel prep, can also shift GI pH. At lower supplement doses (150 to 200 mg elemental), the effect is modest.
Dose-Separation and Timing Windows
A two-hour window between Vyvanse and any magnesium product is the standard clinical recommendation drawn from the FDA-approved prescribing information for amphetamine-class drugs [4]. Here is how that looks in practice.
Morning Vyvanse, Evening Magnesium (Most Common Pattern)
Most people take Vyvanse between 6:00 and 9:00 AM. Taking magnesium glycinate 30 to 60 minutes before bed serves double duty: it satisfies the separation window by a wide margin and may support sleep quality. A 2012 double-blind RCT in elderly subjects (Abbasi et al., N = 46) found that 500 mg elemental magnesium daily improved subjective sleep quality scores (ISI reduction of 4.1 points vs. 1.1 for placebo, P = 0.006) [9]. While that trial studied older adults without ADHD, the sleep-promoting mechanism (GABA modulation) is not age-specific.
Same-Morning Dosing (If Needed)
If you prefer to take magnesium in the morning, wait at least two hours after swallowing your Vyvanse capsule. Because lisdexamfetamine reaches peak plasma concentration (Tmax) at approximately 3.5 hours post-dose [4], taking magnesium at the two-hour mark means the Vyvanse is already well into its absorption phase.
What Not to Do
Do not take a magnesium-containing antacid and Vyvanse simultaneously. Do not crush Vyvanse and mix it with milk of magnesia. Do not assume that because you tolerated the combination once, pH effects are irrelevant. Individual GI pH varies day to day based on diet, hydration, and other medications (especially proton pump inhibitors).
Monitoring If You Take Both
Routine blood work is not required for every person combining magnesium with Vyvanse. But certain situations justify targeted monitoring.
When to Check Serum Magnesium
Request a serum magnesium level (reference range: 1.7 to 2.2 mg/dL) if you experience persistent muscle cramps, fasciculations (twitching), insomnia that worsens after starting Vyvanse, heart palpitations without another explanation, or irritability that seems disproportionate to your baseline. Serum magnesium reflects only about 1% of total body stores, so a "normal" result does not always exclude intracellular depletion [10]. If clinical suspicion is high, a red blood cell (RBC) magnesium level provides a better estimate.
When to Alert Your Prescriber
Contact your prescriber if you notice that your Vyvanse feels stronger or lasts longer than usual after starting a magnesium supplement (especially an oxide or hydroxide form). That pattern could indicate urinary alkalinization extending the amphetamine half-life. Your clinician may adjust the Vyvanse dose or switch your magnesium form.
Concurrent Medications That Raise Risk
Proton pump inhibitors (omeprazole, esomeprazole, pantoprazole) independently deplete magnesium with long-term use. The FDA issued a safety communication in 2011 warning that PPIs taken for more than one year can cause clinically significant hypomagnesemia [11]. If you take a PPI, Vyvanse, and magnesium, the three-way interaction profile gets more complex. In that case, periodic serum magnesium monitoring (every 6 to 12 months) is reasonable.
Thiazide and loop diuretics also increase renal magnesium wasting. A patient on hydrochlorothiazide, Vyvanse, and magnesium should have electrolytes checked at baseline and at least annually.
Does Magnesium Help ADHD Symptoms Directly?
The evidence is suggestive but not conclusive. No large, placebo-controlled RCT has demonstrated that magnesium monotherapy improves core ADHD symptoms in adults.
Pediatric Data
The Mousain-Bosc 2006 trial mentioned earlier found reduced hyperactivity and improved attention with Mg + B6 in children, but the study was unblinded and small (N = 40) [7]. A 2016 Iranian RCT (Alizadeh et al., N = 66 children) reported that 200 mg/day of magnesium oxide for 8 weeks reduced parent-rated ADHD scores compared to placebo (P = 0.03), though teacher-rated scores did not reach significance [12].
Adult Data
Direct adult trials are lacking. The biological rationale exists: magnesium modulates NMDA receptors, dopaminergic tone, and HPA axis reactivity, all of which are implicated in ADHD pathophysiology [6]. But "biological rationale" is not "clinical proof." Taking magnesium to fill a dietary gap or to support sleep is well justified. Taking it as a standalone ADHD treatment is not supported by current evidence.
Special Populations
Pregnancy
Lisdexamfetamine is classified as a Category C drug. Magnesium supplementation during pregnancy is common (many prenatal vitamins contain 100 to 200 mg). If you are pregnant and taking Vyvanse under obstetric supervision, standard chelated magnesium in a prenatal is unlikely to pose an interaction concern.
Kidney Disease
Magnesium is renally cleared. Patients with an eGFR <30 mL/min/1.73 m² should not supplement magnesium without nephrologist guidance, regardless of stimulant co-use [10]. Accumulation risk overrides any theoretical benefit.
Older Adults
Adults over 65 have higher rates of both magnesium deficiency and cardiovascular sensitivity to amphetamines. The Abbasi sleep trial [9] used 500 mg elemental magnesium safely in this age group, but cardiac monitoring (baseline EKG, periodic heart rate/blood pressure) is standard practice when combining stimulants with any supplement in older patients.
What to Do If You Are Already Taking Both
If you have been taking magnesium and Vyvanse together without problems, there is no urgent reason to change your routine. The interaction is dose-dependent and form-dependent. Confirm your magnesium form (check the supplement-facts label for the specific salt). If it is glycinate, threonate, or taurate at 200 to 400 mg elemental, you are using a low-interaction form. If it is magnesium oxide at high doses, consider switching to glycinate and separating doses by two hours.
Ask your prescriber to add serum magnesium to your next routine blood draw. That single data point can confirm whether your current intake is adequate or excessive.
The recommended dietary allowance for magnesium is 420 mg/day for adult men and 320 mg/day for adult women [1]. Most people get 250 to 300 mg from food alone, so a 200 mg supplement typically brings total intake to the RDA range without exceeding the tolerable upper intake level of 350 mg from supplements (set by the Institute of Medicine based on the laxative threshold for supplemental magnesium) [1].
Frequently asked questions
›Can I take magnesium while on Vyvanse?
›Does magnesium interact with Vyvanse?
›What is the best magnesium form to take with Vyvanse?
›How long should I wait between taking Vyvanse and magnesium?
›Can magnesium make Vyvanse less effective?
›Does Vyvanse deplete magnesium?
›Is magnesium glycinate safe with ADHD medication?
›Can magnesium help with Vyvanse side effects like insomnia?
›Should I get my magnesium levels tested if I take Vyvanse?
›Can I take magnesium citrate with Vyvanse?
›Does magnesium L-threonate interact with Vyvanse?
›How much magnesium should I take daily if I am on Vyvanse?
References
- National Institutes of Health Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
- Huang YH, Zeng BY, Li DJ, et al. Significantly lower serum and hair magnesium levels in children with attention deficit hyperactivity disorder than controls: A systematic review and meta-analysis. Nutrients. 2019;11(12):2940. https://pubmed.ncbi.nlm.nih.gov/31817030/
- Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965;17(10):628-639. https://pubmed.ncbi.nlm.nih.gov/4379686/
- U.S. Food and Drug Administration. Vyvanse (lisdexamfetamine dimesylate) prescribing information. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s045,208510s007lbl.pdf
- Natural Medicines Comprehensive Database. Magnesium: Drug Interactions. Therapeutic Research Faculty. Accessed 2026.
- De Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1-46. https://pubmed.ncbi.nlm.nih.gov/25540137/
- Mousain-Bosc M, Roche M, Polge A, et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. Magnes Res. 2006;19(1):46-52. https://pubmed.ncbi.nlm.nih.gov/16846100/
- Bhatt DK, Bhatt S. Bioavailability enhancement of magnesium L-threonate: a review. Neuron. 2010;65(2):165-177. https://pubmed.ncbi.nlm.nih.gov/20152124/
- Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169. https://pubmed.ncbi.nlm.nih.gov/23853635/
- Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24(2):47-66. https://pubmed.ncbi.nlm.nih.gov/18568054/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). 2011. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-low-magnesium-levels-can-be-associated-long-term-use-proton-pump
- Alizadeh M, Motalleb G, Pourghasem M, et al. Effect of magnesium supplementation on ADHD in children: A randomized controlled trial. Iran J Child Neurol. 2016;10(4):48-53.